Project Number 280305 VEN-Cowart-2008 Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Year 2008 View Full Project Details for Development of a Sustained Release Oral Formulation of sGC 1061, A New Therapeutic Agent for the Treatment of Alzheimer's Disease Related Cognitive Deficiency Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 4. Non-clinical Drug Development (small molecules and biologics) g. Oxidative Stress Researcher and Organization Principal Investigator Cowart, Doug Principal Investigator First Name Doug Principal Investigator Last Name Cowart Awardee Organization SGC PHARMA, INC. Awardee State Massachusetts Contact PI Country United States Project Detail Funding Opportunity Announcement Venture Fund RFP FY Overall Cost $295,300 Funding Organization Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Organization Country United States
